Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Chronic obstructive pulmonary disease - Management
Basis for recommendation

Advice about flying

These recommendations are based on the British Thoracic Society (BTS) guidelines on managing people with respiratory disease who are planning air travel [British Thoracic Society, 2004] and on expert opinion from review articles [Johnson, 2003; Tzani et al, 2010].

  • Arterial oxygen levels fall in healthy air travel passengers, and altitude will exacerbate hypoxaemia in people with chronic obstructive pulmonary disease (COPD), especially if they are hypoxic at sea level.
  • People with large bullae may be at risk of pneumothorax, but there is no evidence to indicate at what volume (size of bullae) it is considered unacceptable to travel [British Thoracic Society, 2004].
  • For more information, see www.brit-thoracic.org.uk.

Fitness to fly assessment

This information is based on the BTS guidelines on managing passengers with respiratory disease planning air travel [British Thoracic Society, 2004] and on expert opinion from review articles [Johnson, 2003; Tzani et al, 2010].

Hypoxic challenge test

This information is based on expert opinion from review articles [Johnson, 2003; Tzani et al, 2010].

© NHS Institute for Innovation and Improvement